menu
    • menu

    Company profile for AdipoPharma

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AdipoPharma SAS is a French biotech company committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. The company was created to commercialize the work of its founder, Dr. Vincent Marion PhD, MSc, and Biochemist and researcher at INSERM, the French National Institute for Health and Medical Research. Dr Marion’s team has...
    AdipoPharma SAS is a French biotech company committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. The company was created to commercialize the work of its founder, Dr. Vincent Marion PhD, MSc, and Biochemist and researcher at INSERM, the French National Institute for Health and Medical Research. Dr Marion’s team has spent more than a decade identifying therapeutic targets based on the adipocyte’s specific role in the metabolic effects of insulin resistance and diabetes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AdipoPharmaFrance Flag
    Country
    Country
    France
    Address
    Address
    Parc d’Innovation 650 Boulevard Gonthier d’Andernach 67400 Illkirch-Graf...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.adipopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/adipopharma/?originalSubdomain=fr
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Adipopharma Initiates First-In-Class Type 2 Diabetes Therapy
    Adipopharma Initiates First-In-Class Type 2 Diabetes Therapy

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260552/0/en/AdipoPharma-Enters-Clinic-with-First-in-Class-Therapy-Targeting-Type-2-diabetes-with-the-potential-to-maintain-muscle-mass.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    AdipoPharma Recognized for PATAS at ADA 85th Annual Meeting
    AdipoPharma Recognized for PATAS at ADA 85th Annual Meeting

    30 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/30/3107799/0/en/AdipoPharma-Recognized-at-American-Diabetes-Association-85th-Annual-Meeting-for-PATAS-Its-First-in-Class-Whole-Body-Insulin-Sensitizing-Compound.html

    GLOBENEWSWIRE
    30 Jun 2025
    Share Share
    AdipoPharma Secures Funding for Insulin Resistance Clinical Trials
    AdipoPharma Secures Funding for Insulin Resistance Clinical Trials

    11 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/11/2978500/0/en/French-Biotech-Company-AdipoPharma-Secures-Funding-to-Initiate-Clinical-Trials-for-its-first-in-class-compound-for-Insulin-Resistance.html

    GLOBENEWSWIRE
    11 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search